G, M., V, B., AA, M., E, D., A, A., S, K., . . . BS, L. (2023). In vivo reduction of RAD51-mediated homologous recombination triggers aging but impairs oncogenesis. The EMBO journal, 42(20), e110844. https://doi.org/10.15252/embj.2022110844
Chicago Style (17th ed.) CitationG, Matos-Rodrigues, et al. "In Vivo Reduction of RAD51-mediated Homologous Recombination Triggers Aging but Impairs Oncogenesis." The EMBO Journal 42, no. 20 (2023): e110844. https://doi.org/10.15252/embj.2022110844.
MLA (9th ed.) CitationG, Matos-Rodrigues, et al. "In Vivo Reduction of RAD51-mediated Homologous Recombination Triggers Aging but Impairs Oncogenesis." The EMBO Journal, vol. 42, no. 20, 2023, p. e110844, https://doi.org/10.15252/embj.2022110844.
Warning: These citations may not always be 100% accurate.
